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Abstract
Background Gender-affirming surgeries in female-to-male
(FtM) transgender patients include mostly hysterectomy,
bilateral salpingo-oophorectomy and mastectomy. Some-
times further surgery is performed, such as phalloplasty.
Colpectomy may be performed to overcome gender dys-
phoria and disturbing vaginal discharge; furthermore, it
may be important in reducing the risk of fistulas due to the
phalloplasty procedure with urethral elongation. Colpec-
tomy prior to the reconstruction of the neourethra seems to
reduce fistula rates on the very first anastomosis. Therefore,
at our center, colpectomy has become a standard procedure
prior to phalloplasty and metoidioplasty with urethral
elongation. Colpectomy is known as a procedure with
potentially serious complications, e.g., extensive bloodloss,
vesicovaginal fistula or rectovaginal fistula. Colpectomy
performed via the vaginal route can be a challenging pro-
cedure due to lack of exposure of the surgical field, as
many patients are virginal. Therefore, we investigated
whether robot-assisted laparoscopic hysterectomy with
bilateral salpingo-oophorectomy (TLH–BSO) followed by
robot-assisted laparoscopic colpectomy (RaLC) is an
alternative for the vaginal approach.
Methods Robot TLH/BSO and RaLC as a single-step
procedure was performed in 36 FtM patients in a
prospective cohort study.
Results Median length of the procedure was 230 min
(197–278), which reduced in the second half of the
patients, median blood loss was 75 mL (30–200), and
median discharge was 3 days (2–3) postoperatively. One
patient with a major complication (postoperative bleeding
with readmission and transfusion) was reported.
Conclusion To our knowledge, this is the first report of
RaLC. Our results show that RaLC combined with robot
TLH–BSO is feasible as a single-step surgical procedure in
FtM transgender surgery. Future studies are needed to
compare this technique to the two-step surgical approach
and on its outcome and complication rates of subsequent
phalloplasty.
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Gender dysphoria is a condition in which people suffer
from incongruence between their natal sex and their gender
identity, i.e., their experienced gender [1].
Individuals with gender dysphoria differ in the extent to
which they physically desire to transition to the opposite
sex. The majority of patients will receive cross-sex hor-
mone treatment. Many female-to-male (FtM) patients
request mastectomy, hysterectomy and bilateral salpingo-
oophorectomy (BSO). A subcutaneous mastectomy is
performed, and a male appearance of the thorax is created
[2, 3]. Mastectomy can be combined with hysterectomy
and BSO. Although the majority of FtM patients have the
wish to undergo further genital surgery, for different rea-
sons only few have further surgery, e.g., phalloplasty.
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and Other Interventional Techniques 
At this stage, only few transmen clearly express an
actual wish for phalloplasty with urethral lengthening.
More often transmen ask for colpectomy (removal of
vaginal epithelium) sometime after having had mastec-
tomy and hysterectomy/BSO. Vaginal discharge in gen-
eral and/or increased lubrication as a consequence of
sexual arousal is often experienced negatively and can
interfere with the male self-esteem. Simple closure of the
introitus is no option as vaginal outflow obstruction may
cause accumulation of secretions and hydrocolpos. This
may result in a wish to have a colpectomy performed.
Besides these indications, colpectomy is gaining in
importance preparatory to phalloplasty with urethral
elongation. The anastomosis of the origin ostium ure-
thrae and the reconstructed tube functioning as extended
urethra is known to be very prone to fistulas. Studies on
urethral lengthening in phalloplasty surgery reported 16
to 68% on urethral fistula [4–7]. The incidence of
urethrocutaneous fistula in patients undergoing phallo-
plasty without colpectomy were 27% [5] and 30% [7],
and when a colpectomy was performed, the incidence of
fistula was 16% [6] and 68% [4]. Schaff et al. described
that the majority of the developed fistulas were origi-
nated at the connection site of the lengthened urethra to
the prelaminated urethra and not due to the colpectomy.
Occurrence of urethral fistula after metoidioplasty sur-
gery, including colpectomy, was reported by Perovic
et al. [9], Takamatsu et al. [10] and Djordjevic et al. [8]
to be 7.7, 13.6 and 17.4%, respectively. It is hypothe-
sized—but not yet confirmed—that colpectomy and
consecutive obliteration of the vagina may reduce tensile
forces at the neourethral junction. Therefore, at our
center, colpectomy has become a prerequisite for phal-
loplasty with urethral lengthening.
Colpectomy is often described as a challenging and
complicated operation [11]. As a result of a previously
performed hysterectomy, the bladder may be overlying the
vaginal apex and also the rectovaginal septum may contain
scar tissue due to previous surgery. The resulting alteration
in anatomy poses an elevated risk of bladder, ureteral or
rectal injury. Vesicovaginal, rectovaginal and
ureterovaginal fistula, and intestinal lesions may occur
[12]. These complications induce severe morbidity and
require additional surgery. Although these complications
are rare, they can have a major impact on a patient’s quality
of life. Other intra-operative risks consist of blood loss due
to the extensive blood supply to and from the vaginal wall
(arterial supply: vaginal, uterine, internal pudendal and
middle rectal arteries; venous supply: vaginal venous
plexus draining into internal iliac vessels). The blood
supply is possibly enhanced under influence of supra-
physiological cross-sex hormonal treatment. Postoperative
bleeding can lead to pelvic floor or retroperitoneal hema-
tomas. Other frequently encountered problems are transient
bladder voiding difficulties requiring intermittent
catheterization or indwelling urinary catheter for a longer
period [13].
An additional difficulty in the vaginal approach may be
the access to the vagina. Many patients are nulliparous and
virginal. Furthermore, patients are under continuous cross-
sex hormonal treatment, resulting in a narrow vagina with
considerable atrophy of the epithelium [14, 15] leading to
poor exposure of the operating area [14, 15].
In this paper, we describe a novel technique in which a
robot-assisted laparoscopic hysterectomy (robot TLH) and
BSO is combined with a robot-assisted laparoscopic
colpectomy (RaLC) as a single-step procedure. This tech-
nique may prove to be beneficial over the vaginal colpec-
tomy and laparoscopic hysterectomy as two different
procedures. Besides the advantage of combining two pro-
cedures, RaLC potentially has less complication risk and
shorter hospital stay than the vaginal approach. Although
there have been reports of laparoscopic colpectomy with
low complication rate, they describe that in many cases,
part of the vagina still needs to be removed vaginally [16].
We chose the robot over conventional laparoscopy because
of a potential larger learning curve with conventional
laparoscopic colpectomy, the need for vaginal removal of
remnant vagina, 3D high-definition camera for fine surgery
using the robot, low intra-abdominal pressure possibility




We performed a single-center prospective cohort study in
36 female-to-male transgender patients. Patients underwent
the procedure as described below after informed consent
was obtained. The study protocol (2016.224) has been
approved by the Medical Ethics Review Committee of VU
University Medical Centre (OHRP number IRB00002991).
The FWA number assigned to VU University Medical
Center is FWA00017598.
Patients were included between July 2011 and June
2015. One gynecologist performed all procedures with
extensive experience in robotic surgery including robot-





and colpectomy in four steps
1. Vaginal part of the colpectomy:
With the introduction of the uterine mobilizer (V-Care
Uterine Manipulator, ConMed, Utica, USA) vaginally, a
suture is placed in the vaginal epithelium 10 mm proximal
of the urethra as a bordering landmark for the colpectomy
(see Fig. 1A, B). Vaginal epithelium 15 mm around the
ostium urethrae is not removed as this tissue will be used
during urethra elongation to create a second protective
layer covering the urethral anastomosis. A rectum cannula
is placed in order to identify the rectum during the
colpectomy.
2. Positioning and trocar placement:
A small incision was made approximately 20 cm above
the pubic bone for insertion of a Veress needle to create a
pneumoperitoneum up to 20 mmHg. A total of 5 trocars
were used (4 for the robot arms and 1 for the assistant). The
da Vinci surgical system (Intuitive Surgical, Inc., Sun-
nyvale, CA, USA) was positioned to the patient’s right
side, with a scrub nurse or assistant to the left side of the
patient. The robotic instruments used were the monopolar
scissors, bipolar fenestrated forceps and the grasping for-
ceps. During surgery, pneumoperitoneum was kept at
8–10 mmHg. The patient was now placed in Trendelen-
burg position for optimal visualization of the operating
area.
3. TLH and BSO:
A robot-assisted TLH and BSO are performed according
to a standardized protocol [17, 18]. The ureters are later-
alized and dissected up to the vesicoureteric junction in
preparation of the colpectomy. The uterus and adnexa are
removed through the vagina. Maintenance of pneu-
moperitoneum is accomplished by introducing a glove-
covered gauze in the distal part of the vagina at the rim of
the introitus. Hereafter, the robot-assisted colpectomy is
performed.
4. Robot-assisted laparoscopic colpectomy (Video):
Anteriorly, the epithelium is dissected carefully with
monopolar scissors to ensure the coagulation of the well-
defined vasculature of the vaginal wall. Dissection is
completed to approximately one centimeter proximal of the
urethra (marked by the suture, see Fig. 1B) and posteriorly
up to the level of the posterior commissure. The epithelium
removed is as thin as possible to prevent nerve injury to
adjacent structures, to prevent fistula to bladder, urethra or
rectum, and to prevent bleeding from the perivaginal
plexus. It is necessary to dissect the ureters up to the
vesicoureteric junction in order to visualize the ureters
during removal of proximal vaginal epithelium. After
removal of the entire vaginal wall, the vaginal apex is
sutured laparoscopically by suturing the remnants of the
rectovaginal septum and endopelvic fascia of the vesicov-
aginal space together. During this step, it is crucial to
carefully pay attention to the route of both ureters to avoid
lesions or kinking. After hemostasis, the instruments are
removed and the abdominal incisions closed. Finally, any
residual epithelium at the level of the introitus is removed
vaginally and the bulbocavernosus muscles are
Fig. 1 A Bordering landmark
from the outside prior to
colpectomy. Vaginal epithelium
15 mm around the ostium
urethrae is necessary for the
urethral anastomosis for further
phalloplasty surgery. A suture
needs to be placed prior to
laparoscopic colpectomy to
define this border. During the
colpectomy, the suture is used a
landmark as shown in (B).
B Bordering landmark (A) from
the inside during the
colpectomy, vaginal epithelium
(B), urether (C) and the blue




approximated with a few sutures to narrow the introitus. As
a standard procedure, an absorbable hemostat is applied to
the surgical field to prevent diffuse bleeding. The introitus
is not closed, as access for the urethral anastomosis at a
later stage is required.
Postoperative care
Postoperative care was congruent with our standard vaginal
colpectomy protocol consisting of bed rest during the first
day after surgery and bladder training at postoperative day
2. Bladder training consisted of clamping the transurethral
catheter twice for 3–4 h. When the urge to urinate is pre-
sent both times, the catheter was removed. Spontaneous
micturition must occur within 3–4 h. Postvoid residual
urinary volume (PVR) was tested ultrasonographically
after spontaneous micturition, and PVR must be\100 mL
repeatedly (twice). Patients with a PVR of more than
100 mL were treated with an indwelling urinary catheter
for 24 h. After successful bladder training and voiding,
patients were discharged.
Results
We performed robot-assisted TLH/BSO and RaCL in a
total of 36 patients. Patient characteristics and results are
shown in Table 1. All patients were nulliparous, and 30 of
36 patients (83.3%) were virginal. Three patients had
previous minor abdominal surgery (appendectomy), and 33
had undergone a mastectomy. No conversions to laparo-
tomy were encountered during RaLC.
Length of the procedure was acceptable with a median
of 230 min (197–278), and median blood loss was
75 mL (30–200). Despite the fact that a very experienced
robot surgeon executed all procedures, a clear learning
curve can be observed in terms of intra-operative blood
loss and gradual reduction in surgery time. Comparing
the last 18 cases with the first 18 cases, median surgery
time reduced from 278 to 197 min (p = 0.00) and
median blood loss reduced from 175 to 30 ml (p = 0.01)
(Figs. 2, 3).
We defined our complications as minor or major
according to the study of Mourits et al. [19]. Some com-
plications occurred: mainly minor and related to urinary
voiding (see Table 1). One patient (2.8%) with a major
complication (postoperative bleeding with readmission and
transfusion) and 7 patients (19%) with minor complications
were reported (2 urinary tract infection (UTI) and 6 urinary
retention needing a catheter).
Median hospital stay was 3 (2–3) days postoperatively.
At discharge, six patients experienced urine voiding
problems requiring an indwelling catheter for a longer
period of time (in accordance with standard urological
protocols). After 72 h, PVR was tested again. In 5 patients,
PVR was below 100 mL and the catheter was removed.
Only one patient still had ongoing urine voiding problems
after 72 h with bladder spasms due to a UTI. The urinary
catheter was kept in place, and oral antibiotics were started.
After an additional 48 h, the catheter was successfully
removed.
Six out of eight patients had their catheters successfully
removed at day 1 postoperatively after bladder training and
sonographic confirmation of a PVR\100 mL.
Table 1 Patient characteristics
Number of patients N = 36
Median age at surgery (years) (IQR) 23.5 (19.5–28.4)
Median BMI (kg/m2) (IQR) 22.2 (21–24.7)
Parity 36/36 nulliparous (100%)
Virgin 30/36 (83.3%)
Previous abdominal surgery 3/36 (8.3%)
Median bloodloss during surgery (mL) (IQR) 75 (30–200)
Median OR time (min) (IQR) 230 (197–278)
Median hospital stay (days) (IQR) 3 (2–3)
Conversion to laparotomy 0/36 (0%)
Major complications 1/36 (2.8%)
Postoperative bleeding with readmission 1/36 (2.8%)
Fistula (vesicovaginal or rectovaginal) 0/36 (0%)
Minor complications 8/36 (22%)
Urinary tract infection 2/36 (5.6%)
Urinary retention needing catheter 6/36 (16.7%)
Data are reported as median (interquartile range) or as n (percentage)
Surg Endosc
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Successful catheter removal continued on day 2 (13/17
patients) and day 3 (8/11 patients). The 8 patients, for
whom the catheters were not successfully removed, had
their catheter removed 48 h (2 patients), 72 h (6 patients)
and 5 days after surgery (1 patient).
One patient, in the group of the first 18 operated
patients, was readmitted 8 days after discharge because of
vaginal bleeding. Bloodloss was most likely due to
bleeding of the vaginal wall. At admission, blood loss was
minimal and rectal palpation did not show a hematoma.
Bleeding stopped spontaneously; however, 2 units of
packed cells was administered due to significant hemo-
globin drop (hemoglobin 7.7 mmol/L with hematocrit
0.36 L/L to hemoglobin 4.7 mmol/L with hematocrit




Herein, we have established that RaLC is a feasible pro-
cedure in FtM transgender patients; a clear learning curve
could be observed concerning surgery time and blood loss.
In this series of patients, we have encountered one major
postoperative complication (1 patient with postoperative
bleeding) and 7 minor postoperative complications (5
patients with urine voiding problems, 1 patient with an UTI
and 1 patient with urine voiding problems and an UTI). All
8 complications were successfully treated or resolved with
conservative treatment.
Strengths and limitations
Although this study has its limitations, such as a small
number of patients and a relatively short follow-up period,
the study we present shows the safety, feasibility and
efficacy of the robot-assisted colpectomy combined with
robot TLH/BSO as a single-step surgical procedure.
Consistent with the IDEAL criteria (Idea, Development,
Exploration, Assessment and Long-term study) for the
evaluation and implementation of an innovational surgical
procedure, this is a prospective development study with an
initial small group of patients, where a clear description of
the surgery is outlined, without omissions and including
learning curves as well. As these characteristics represent
the stage 2a ‘Development’ based on these IDEAL criteria,
this stage may be assigned to this study [20].
Comparison to other data and clinical implications
In this study, we did not encounter severe complications
such as fistula. However, the number of patients included
in this pilot study is too low to conclude (yet) that RaLC is
a safer procedure than vaginal colpectomy. Also there is
very little literature available showing complication rates
for vaginal colpectomy in patients.
Vaginal (partial) colpectomy is mainly described in
patients with deep infiltrating endometriosis and in patients
with cancer and may therefore have higher complication
risk than our patient category. Complications described are
mostly urological: 3.5–14.3% persistent urinary retention
[12, 13, 21], and one paper describes 12.5% bladder per-
foration (1/8 patients) [22]. Complication rates for fistula
(vesicovaginal or rectovaginal) are not reported in the lit-
erature, although there is a reported 0.7% incidence on
rectal lacerations during surgery that involved the posterior
vaginal wall [23]. In this series of patients, published by
Hoffman et al. [23], the majority of procedures to the
posterior vaginal wall included was for prolapse; other
procedures were for neoplasia and transgender. In the 6
patients included, there was one serious adverse event: a
rectal laceration of 2 cm (1 of 6 patients; 16.6% in this
particular subgroup) [23]. None of these patients had fur-
ther postoperative sequelae.
Sehnal et al. [24] published in 2008 a prospective ran-
domized controlled trial in which they compared 3 methods
of hysterectomy (through median laparotomy, Pfannenstiel
incision or laparoscopy) in 61 FtM patients. The authors
conclude that TLH is the best treatment because of better
wound healing, low complication rate, short admission
time and no damage to the rectus abdominis muscle and
epigastric vessels (important for phalloplasty using a rectus
abdominis flap). In none of the cases, a direct (vaginal)
colpectomy was performed. Furthermore, they did not
Fig. 2 Learning curve for operating time in minutes
Fig. 3 Learning curve for bloodloss in mL
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include vaginal hysterectomy as they deemed this proce-
dure too difficult in this patient group. Kaiser et al. [25]
published in 2011 a series of 106 FtM patients undergoing
bilateral subcutaneous mastectomy, vaginal hysterectomy
with BSO and complete vaginal colpectomy in the same
surgical session. Although a series of more than 100
colpectomies in a transgender population is remarkable,
Kaiser et al. did not describe any further detail regarding
technique and results of colpectomy specifically. The
conversion risk to laparotomy in this study was 2.8% of
cases, and the major complication rate was 5.4% (bowel
perforation 0.9%, bladder perforation 0.9%, compartment
syndrome 1.8%, intra-abdominal bleeding 1.8%) [25.] If
the vaginal approach is preferred and the narrow vagina
limits appropriate access, one may consider the Schuchardt
incision. This incision has been used for radical vaginal
hysterectomy. Briefly, the skin is incised over 3–4 cm from
the lower and middle third of the left labium majus. The
vaginal wall, which is now under tension, is incised down
to the levator ani muscle, and the rectum is displaced. The
layers of the perineum are divided to expose the levator,
which is then divided almost completely [26]. Schuchardt
technique is known to cause considerable morbidity, such
as an increased risk of bleeding, wound dehiscence, nerve
damage, vaginal vault prolapse and in rare cases bowel
evisceration. The preceding clearly shows that laparoscopic
hysterectomy in patients is not inferior to vaginal
hysterectomy.
Benefits of our technique over the vaginal route include
an excellent exposure of the operating area with a complete
overview of the vaginal epithelium, blood loss is minimal,
postoperative recovery is fast with rapid postoperative
mobilization and discharge, and there is almost immediate
regain of bladder function after surgery. Admission to the
hospital is longer after RaLC than after other laparoscopic
procedures. This might be due to prudence with a new
technique and unknown postoperative sequelae. This is
underlined by the adjustment of the protocol concerning
admission period during our cohort study. Further decrease
in admission period is feasible. This is in line with the fact
that more and more laparoscopic and robotic-assisted
hysterectomies are executed in daycare [27–32].
Since patient recovery in our study was fast, we con-
sidered removing the catheter immediately after surgery
instead of day 2. Joshi et al. [33] found no difference in
UTI between patients who had their catheter removed
immediately after an abdominal hysterectomy compared to
patients who had their catheter removed after 24 h, while
recatheterization was slightly more frequent in the early
removal group. Although these patients are not completely
comparable to colpectomy patients, it seems that early
removal of urinary catheters in colpectomy patients (day 1)
should be feasible.
The clinical implications are not yet clear but may
include a faster return to work, less complications and less
blood loss. Although these results are promising, this is a
complex procedure even for the experienced robot surgeon
and a clear learning curve is seen. Implementation of this
technique on a larger scale and by more surgeons might not
show the same positive results. The technique is still in the
developmental phase according to the IDEAL criteria.
Therefore, we advise to utilize this technique solely in a
highly specialized center in a research setting in order to
evaluate the technique on a larger scale.
To our knowledge, this is the first study to report on
RaLC combined with robot TLH and BSO in FtM patients.
Future research should be directed toward quality of life
assessment and long-term follow-up. Furthermore, RaLC
in combination with robot TLH/BSO needs to be compared
to the standard two-step procedure of TLH/BSO and con-
secutive vaginal colpectomy. Also analysis should include
complication rates of subsequent phalloplasty procedures.
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